These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 15894352
21. Platelet-dependent thrombin generation after in vitro fibrinolytic treatment. Aronson DL, Chang P, Kessler CM. Circulation; 1992 May; 85(5):1706-12. PubMed ID: 1533349 [Abstract] [Full Text] [Related]
23. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin. Doolittle RF, Pandi L. Biochemistry; 2006 Feb 28; 45(8):2657-67. PubMed ID: 16489759 [Abstract] [Full Text] [Related]
28. Plasmin accelerates platelet-dependent prothrombinase formation without activating the platelets. Liu L, Freedman J, Hornstein A, Dewar L, Blajchman MA, Ofosu FA. Br J Haematol; 1996 Feb 28; 92(2):458-65. PubMed ID: 8603017 [Abstract] [Full Text] [Related]
29. Stimulation of plasmin activity by aspirin. Milwidsky A, Finci-Yeheskel Z, Mayer M. Thromb Haemost; 1991 Apr 08; 65(4):389-93. PubMed ID: 1829277 [Abstract] [Full Text] [Related]
30. Plasminogen interactions with immobilized fibrinogen. Adelman B, Quynn P. Thromb Haemost; 1989 Dec 29; 62(4):1078-82. PubMed ID: 2617455 [Abstract] [Full Text] [Related]
31. gammaA/gamma' fibrinogen inhibits thrombin-induced platelet aggregation. Lovely RS, Rein CM, White TC, Jouihan SA, Boshkov LK, Bakke AC, McCarty OJ, Farrell DH. Thromb Haemost; 2008 Nov 29; 100(5):837-46. PubMed ID: 18989528 [Abstract] [Full Text] [Related]
32. Purification and characterization of a stimulator of plasmin generation from the antiangiogenic agent Neovastat: identification as immunoglobulin kappa light chain. Boivin D, Provençal M, Gendron S, Ratel D, Demeule M, Gingras D, Béliveau R. Arch Biochem Biophys; 2004 Nov 15; 431(2):197-206. PubMed ID: 15488468 [Abstract] [Full Text] [Related]
33. Binding and activation of plasminogen at the surface of Staphylococcus aureus. Increase in affinity after conversion to the Lys form of the ligand. Kuusela P, Saksela O. Eur J Biochem; 1990 Nov 13; 193(3):759-65. PubMed ID: 1701146 [Abstract] [Full Text] [Related]
35. Multimerin 1 binds factor V and activated factor V with high affinity and inhibits thrombin generation. Jeimy SB, Fuller N, Tasneem S, Segers K, Stafford AR, Weitz JI, Camire RM, Nicolaes GA, Hayward CP. Thromb Haemost; 2008 Dec 13; 100(6):1058-67. PubMed ID: 19132231 [Abstract] [Full Text] [Related]
36. Effect of aprotinin and recombinant variants on platelet protease-activated receptor 1 activation. Day JR, Haskard DO, Taylor KM, Landis RC. Ann Thorac Surg; 2006 Feb 13; 81(2):619-24. PubMed ID: 16427862 [Abstract] [Full Text] [Related]
38. The binding and processing of plasminogen by Balb/c 3T3 and SV3T3 cells. Tobler J, Krieger M, Stroud RM. J Cell Physiol; 1981 Aug 13; 108(2):277-90. PubMed ID: 6267086 [Abstract] [Full Text] [Related]
39. Epinephrine induces intracellular Ca2+ mobilization in thrombin-desensitized platelets: a role for GPIb-IX-V. Ghilotti M, Lova P, Balduini C, Torti M. Platelets; 2007 Mar 13; 18(2):135-42. PubMed ID: 17365862 [Abstract] [Full Text] [Related]
40. Dual P2Y 12 receptor signaling in thrombin-stimulated platelets--involvement of phosphoinositide 3-kinase beta but not gamma isoform in Ca2+ mobilization and procoagulant activity. van der Meijden PE, Schoenwaelder SM, Feijge MA, Cosemans JM, Munnix IC, Wetzker R, Heller R, Jackson SP, Heemskerk JW. FEBS J; 2008 Jan 13; 275(2):371-85. PubMed ID: 18081863 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]